WELDON STEVEN W (CFO) sold 4.9% of their position (200K shares) of GT BIOPHARMA, INC. on the open market
Open‑market sale worth $60.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 12/18/2020ACC: 0001356710-20-000002
DirectorOfficer10% Owner· CFO
Since Aug 2019
-200K
Net shares
Net seller
$60.5K
Total sold
4
Open market trades
0B · 4S
4
Total transactions
200K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
−50K
Price / share
$0.30
Trade value
$15K
% of position
1.2%
12/16/2020
4.10M→4.05M
Common Stock
Direct
Shares
−50K
Price / share
$0.30
Trade value
$15K
% of position
1.2%
12/17/2020
4.05M→4M
Common Stock
Direct
Shares
−50K
Price / share
$0.31
Trade value
$15.50K
% of position
1.2%
12/17/2020
4M→3.95M
Common Stock
Direct
Shares
−50K
Price / share
$0.30
Trade value
$15K
% of position
1.3%
12/18/2020
3.95M→3.90M
Total
Net shares
−200K
Net value
-$60.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/16/2020 | S · Sale | −50K | $0.30 | $15K | 1.2% | 4.10M | 4.05M |
| Common Stock Direct | 12/17/2020 | S · Sale | −50K | $0.30 | $15K | 1.2% | 4.05M | 4M |
| Common Stock Direct | 12/17/2020 | S · Sale | −50K | $0.31 | $15.50K | 1.2% | 4M | 3.95M |
| Common Stock Direct | 12/18/2020 | S · Sale | −50K | $0.30 | $15K | 1.3% | 3.95M | 3.90M |
| Total | −200K | -$60.50K | ||||||
Derivative Transactions0
No derivative transactions reported